Nuclear magnetic resonance (NMR) study of the effect of cisplatin on the metabolic profile of MG-63 osteosarcoma cells

Journal of Proteome Research

Volumn 9, Issue 11, 2010, Pages 5877-5886

  Duarte, Iola F ^a   Lamego, Inês ^a   Marques, Joana ^a   Marques, M Paula M ^b   Blaise, Benjamin J ^c   Gil, Ana M ^a  

^a UNIVERSITY OF AVEIRO   (Portugal)

^b UNIVERSITY OF COIMBRA   (Portugal)

^c UNIVERSITÉ DE LYON   (France)

Author keywords

cancer; cancer therapy; cisplatin; metabonomics; MG 63 cells; NMR spectroscopy; osteosarcoma

Indexed keywords

ACETIC ACID; ALANINE; ARGININE; ASPARTIC ACID; CISPLATIN; CREATINE; GLUTAMIC ACID; GLUTATHIONE; GLYCINE; HISTIDINE; ISOLEUCINE; LEUCINE; LIPID; LYSINE; METHIONINE; PHENYLALANINE; PROLINE; THREONINE; TYROSINE; URIDINE; URIDINE DIPHOSPHATE; VALINE;

ARTICLE; CELL METABOLISM; CONTROLLED STUDY; DRUG EFFECT; DRUG EXPOSURE; HUMAN; HUMAN CELL; METABOLITE; MULTIVARIATE ANALYSIS; OSTEOSARCOMA CELL; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; TIME;

ALCOHOLS; AMINO ACIDS; CHOLINE; CISPLATIN; HUMANS; KINETICS; LIPIDS; MAGNETIC RESONANCE SPECTROSCOPY; METABOLOME; OSTEOSARCOMA;

EID: 78149379979     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr100635n     Document Type: Article

References (33)

1. Chou, A. J.; Geller, D. S.; Gorlick, R. Therapy for osteosarcoma: where do we go from here Pediatric Drugs 2008, 10 (5) 315-327
2. Chou, A. J.; Gorlick, R. Chemotherapy resistance in osteosarcoma: current challenges and future directions Expert Rev. Anticancer Ther. 2006, 6 (7) 1075-1085
3. Chung, Y. L.; Griffiths, J. R. Using metabonomics to monitor anticancer drugs, in Oncogenes Meet Metabolism; Spinger-Verlag: Berlin, 2008; pp 55 - 78.
4. Merz, A. L.; Serkova, N. J. Use of nuclear magnetic resonance-based matabolomics in detecting drug resistance in cancer Biomarkers Med. 2009, 3 (3) 289-306
5. Griffin, J. L.; Shockcor, J. P. Metabolic profiles of cancer cells Nat. Rev. Cancer 2004, 4, 551-561
6. Lutz, N. W. From metabolic to metabolomic NMR spectroscopy of apoptotic cells Metabolomics 2005, 1 (3) 251-268
7. Khoo, S. H. G.; Al-Rubeai, M. Metabolomics as a complementary tool in cell culture Biotechnol. Appl. Biochem. 2007, 47, 71-84
8. Duarte, I. F.; Lamego, I.; Rocha, C.; Gil, A. M. NMR metabonomics for mammalian cell metabolism studies Bioanalysis 2009, 1 (9) 1597-1614
9. Santini, M. T.; Rainaldi, G.; Romano, R.; Ferrante, A.; Clemente, S.; Motta, A.; Indovina, P. L. MG-63 human osteosarcoma cells grown in monolayer and as three-dimentional tumor spheroids present a different metabolic profile: a 1H NMR study FEBS Lett. 2004, 557, 148-154
10. Santini, M. T.; Romano, R.; Rainaldi, G.; Ferrante, A.; Motta, A.; indovina, P. L. Increases in 1H-NMR mobile lipids are not always associated with overt apoptosis: evidence from MG-63 human osteosarcoma three-dimensional spheroids exposed to a low dose (2 Gy) of ionizing radiation Radiat. Res. 2006, 165, 131-141
11. Santini, M. T.; Romano, R.; Rainaldi, G.; Indovina, P.; Ferrante, A.; Motta, A.; Indovina, P. L. Temporal dynamics of 1H-NMR-visible metabolites during radiation-induced Aapoptosis in MG-63 human osteosarcoma Spheroids Radiat. Res. 2006, 166, 734-745
12. Santini, M. T.; Romano, R.; Rainaldi, G.; Ferrante, A.; Indovina, P.; Motta, A.; Indovina, P. L. 1H-NMR evidence for a different response to the same dose (2 Gy) of ionizing radiation of MG-63 human osteosarcoma cells and three-dimensional spheroids Anticancer Res. 2006, 26 (1A) 267-281
13. Loiseau, D.; Morvan, D.; Chevrollier, A.; Demidem, A.; Douay, O.; Reynier, P.; Stepien, G. Mitochondrial bioenergetic background confers a survival advantage to HepG2 cells in response to chemotherapy Mol. Carcinogenesis 2009, 48, 733-741
14. Cooper, W. A.; Bartier, W. A.; Rideout, D. C.; Delikatny, E. J. 1H NMR visible lipids are induced by phosphonium salts and 5-fluorouracil human breast cancer cells Magn. Reson. Med. 2001, 45, 1001-1010
15. Brisdelli, F.; Iorio, E.; Knijn, A.; Ferretti, A.; Marcheggiani, D.; Lentie, L.; Strom, R. Two-step formation of 1H NMR visible mobile lipids during apoptosis of paclitaxel-treated K562 cells Biochem. Pharmacol. 2003, 65, 1271-1280
16. Sathasivam, N.; Brammah, S.; Wright, L. C.; Delikatny, E. Inhibition of tetraphenylphosphonium-induced NMR-visible lipid accumulation in human breast cells by chlorpromazine Biochim. Biophys. Acta 2003, 1633, 149-160
17. Knijn, A.; Brisdelli, F.; Ferretti, A.; Iorio, E.; Marcheggiani, D.; Bozzi, A. Metabolic alterations in K562 cells exposed to taxol and tyrphostin AG957: 1H NMR and biochemical studies Cell Biol. Int. 2005, 29, 890-897
18. Al-Saffar, N. M. S.; Troy, H.; de Molina, A. R.; Jackson, L. E.; Madhu, B.; Griffiths, J. R.; Leach, M. O.; Workman, P.; Lacal, J. C.; Judson, I. R.; Chung, Y.-L. Noninvasive magnetic resonance spectroscopic pharmacodynamic markers of the choline kinase inhibitor MN58b in human carcinoma models Cancer Res. 2006, 66 (1) 427-434
19. Fan, T. W.-M.; Higashi, R. M.; Lane, A. N. Integrating metabolomics and transcriptomics for probing Se anticancer mechanisms Drug Metab. Rev. 2006, 38, 707-732
20. Morse, D. L.; Raghunand, N.; Sadarangani, P.; Murthi, S.; Job, C.; Day, S.; Howison, C.; Gillies, R. J. Response of choline metabolites to docetaxel therapy is quantified in vivo by localized 31P MRS of human breast cancer xenografts and in vitro by high-resolution 31P NMR spectroscopy of cell extracts Magn. Reson. Med. 2007, 58, 270-280
21. Kominsky, D. J.; Klawitter, J.; Brown, J. L.; Boros, L. G.; Melo, J. V.; Eckhardt, S. G.; Serkova, N. Abnormalities in glucose uptake and metabolism in imatinib-resistant human BCR-ABL-positive cells Clin. Cancer Res. 2009, 15 (10) 3442-3450
22. Tiziani, S.; Lodi, A.; Khanim, F. L.; Viant, M. R.; Bunce, C. M.; Günter, U. L. Metabolomic profiling of drug responses in acute myeloid leukaemia cell lines PLOS One 2009, 4 (1) 1-10
23. Lindon, J. C.; Beckonert, O. P.; Holmes, E.; Nicholson, J. High-resolution magic angle spinning NMR spectroscopy: Application to biomedical studies Prog. Nucl. Magn. Reson. Spectrosc. 2009, 55 (2) 79-100
24. Sitter, B.; Bathen, T. F.; Tessem, M.-B.; Gribbestad, I. S. High-resolution magic angle spinning (HR MAS) MR spectroscopy in metabolic characterization of human cancer Prog. Nucl. Magn. Reson. Spectrosc. 2009
25. Duarte, I. F.; Marques, J.; Ladeirinha, A. F.; Rocha, C.; Lamego, I.; Calheiros, R.; Silva, T. M.; Marques, M. P. m.; Melo, J. B.; Carreira, I. M.; Gil, A. M. Analytical approaches toward successful human cell metabolome studies by NMR spectroscopy Anal. Chem. 2009, 81, 5023-5032
26. Griffin, J. L.; Pole, J. C. M.; Nicholson, J. K.; Carmichael, P. L. Cellular environment of metabolites and a metabonomic study of tamoxifen in endometrial cells using gradient high resolution magic angle spinning 1H NMR spectroscopy Biochim. Biophys. Acta 2003, 1619, 151-158
27. Morvan, D.; Demidem, A.; Papon, J.; Madelmont, J. C. Quantitative HRMAS proton total correlation spectroscopy applied to cultured melanoma cells treated by chloroethyl nitrosourea: demonstration of phospholipid metabolism alterations Magn. Reson. Med. 2003, 49, 241-248
28. Borel, M.; Degoul, F.; Communal, Y.; Mounetou, E.; Bouchon, B.; C-Gaudreault, R.; Madelmont, J. C.; Miot-Noirault, E. N-(4-iodophenyl)-N0-(2- chloroethyl)urea as a microtubule disrupter: in vitro and in vivo profiling of antitumoral activity on CT-26 murine colon carcinoma cell line cultured and grafted to mice Br. J. Cancer 2007, 96, 1684-1691
29. Durkin, W. S.; Ghanta, V. K.; Balch, C. M.; Davis, D. W.; Hiramoto, R. N. A methodological approach to the prediction of anticancer drug effects in humans Cancer Res. 1979, 39, 402-407
30. Li, Y. L.; Lin, A. W.; Zhang, X. J.; Wang, Y. Q.; Wang, X. L.; Goodrich, D. W. Cancer cells and normal cells differ in their requirements for Thoc1 Cancer Res. 2007, 67, 6657-6664
31. Blaise, B. J.; Shintu, L.; Elena, B.; Emsley, L.; Dumas, M.-E.; Toulhoat, P. Statistical recoupling prior to significance testing in nuclear magnetic resonance based metabonomics Anal. Chem. 2009, 81, 6242-6251
32. Lyng, H.; Sitter, B.; Bathen, T. F.; Jensen, L. R.; Sundfør, K.; Kristensen, G. B.; Gribbestad, I. S. Metabolic mapping by use of high-resolution magic angle spinning 1H MR spectroscopy for assessment of apoptosis in cervical carcinomas BMC Cancer 2007, 7, 11
33. Glunde, K.; Jacobs, M. A.; Pathaka, A. P.; Artemov, D.; Bhujwalla, Z. M. Molecular and functional imaging of breast cancer NMR Biomed. 2009, 22 (1) 92-103